Ethical dilemma in fetal stem cell research – UK stroke study
“The world’s first clinical trial of brain stem cells to treat stroke has recorded no adverse effects to date, BBC News has reported. The BBC website reports that research using stem cells to treat strokes “is set to move to its next phase” after independent assessors approved continuation of the trial of the experimental treatment. So far the therapy has been tested on three patients left disabled by strokes.”
via Stroke stem cell trial gets extended – Health News – NHS Choices.
The problem is that the cells were harvested from the brains of 12 week old aborted fetuses. The researchers at the University of Glascow, Scotland, working with the company, “ReNeuron,” harvested the cells, manipulated them with genes to induce them to become immortal stem cells that will divide infinitely and now have what appears to an endless supply of proprietary cells for future research and treatments of stroke victims.
More at LifeEthics.org: Ethical dilemma in fetal stem cell research – UK stroke study | LifeEthics.